Main navigation

• Home
• About us
• Medicines
• Research
• Careers
• Responsibility
• Partnering
• Media
  • Corporate reports
  • Facts, products, pipeline
  • Events calendar
  • Media contacts
  • Press releases
  • Photo library
  • Broadcast Centre
• Investors

You are here

• Home

• Media

Here you will find our corporate press releases, details on upcoming events and other useful information for business and financial media.

• Latest news collapse

  • 19 October 2009 Patients Taking VIMOVO(TM) Showed Decrease in incidence of NSAID Associated Ulcers

    AstraZeneca and POZEN Inc. today announced pivotal data from two POZEN clinical trials that were presented at the American College of Rheumatology (ACR) 2009 Annual Scientific Meeting in Philadelphia, PA.

  • 16 October 2009 AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™

    AstraZeneca and POZEN, Inc. today announced that they have submitted a Marketing Authorisation Application (MAA) in the European Union via the Decentralised Procedure (DCP) for VIMOVO.

  more news

  • previous
  • • 1
    • 2
    • 3
    • 4
    • 5
  • next

  Financial results collapse

  Third Quarter & Nine Months results 2009 announced Thursday, 29 October
  2009.

  • View details of the event
  • View financial calendar

  Photo & video library collapse

  • Here you can download pictures from our photo library
  • Broadcast footage of AstraZeneca products and activities is available from our Broadcast Centre (requires registration)

• Key Facts collapse

  • We are a world leading pharmaceutical company with a world-class biologics capability.
  • We are active in over 100 countries with a growing presence in important emerging markets including China; corporate office in London, UK; and major R&D sites in Sweden, the UK and the US.
  • We employ over 65,000 people (51% in Europe, 32% in the Americas and 17% in Asia, Africa and Australasia).
  • Alongside our commitment to competitiveness and performance, we continue to be led by our core values to achieve sustainable success.
  • More facts about AstraZeneca

  Research & Development collapse

  We focus our research on six disease areas where we believe our skills and experience can make the most difference.

  • Read about our disease area focus
  • Read about our pipeline progress
  • Review our pipeline summary

Not signed in

Page tools

• Print
• Bookmark this page

Share price